SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-187357
Filing Date
2019-07-01
Accepted
2019-07-01 16:03:03
Documents
6
Period of Report
2019-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d11726d8k.htm 8-K 19532
2 EX-10.1 d11726dex101.htm EX-10.1 153952
3 GRAPHIC g11726g12m48.gif GRAPHIC 53210
4 GRAPHIC g11726g27u27.gif GRAPHIC 60214
5 GRAPHIC g11726g50v91.gif GRAPHIC 52074
6 GRAPHIC g11726g71t75.gif GRAPHIC 104109
  Complete submission text file 0001193125-19-187357.txt   546259
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 19933202
SIC: 2834 Pharmaceutical Preparations